Scilex Pharms Drug Patent Portfolio
Scilex Pharms owns 3 orange book drugs protected by 18 US patents Given below is the list of Scilex Pharms's drug patents along with their expiration dates.
| Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Status |
|---|---|---|---|
| US10226423 | Colchicine drug-to-drug interactions | 20 Dec, 2037 | Active |
| US10383820 | Colchicine drug-to-drug interactions | 22 Nov, 2036 | Active |
| US10383821 | Colchicine drug-to-drug interactions | 22 Nov, 2036 | Active |
| US9907751 | Composition and method of use of colchicine oral liquid | 22 Nov, 2036 | Active |
| US10376527 | Oral composition of celecoxib for treatment of pain | 27 May, 2036 | Active |
| US10722456 | Oral composition of celecoxib for treatment of pain | 27 May, 2036 | Active |
| US10799517 | Oral composition of celecoxib for treatment of pain | 27 May, 2036 | Active |
| US9572819 | Oral composition of celecoxib for treatment of pain | 27 May, 2036 | Active |
| US9795620 | Oral composition of celecoxib for treatment of pain | 27 May, 2036 | Active |
| US9949990 | Oral composition of celecoxib for treatment of pain | 27 May, 2036 | Active |
| US10765640 | Non-aqueous patch | 10 May, 2031 | Active |
| US10765749 | Non-aqueous patch | 10 May, 2031 | Active |
| US11278623 | Non-aqueous patch | 10 May, 2031 | Active |
| US11786455 | Non-aqueous patch | 10 May, 2031 | Active |
| US11793766 | Non-aqueous patch for the relief of pain | 10 May, 2031 | Active |
| US9283174 | Non-aqueous patch | 10 May, 2031 | Active |
| US9925264 | Non-aqueous patch | 10 May, 2031 | Active |
| US9931403 | Non-aqueous patch | 10 May, 2031 | Active |
Latest Legal Activities on Scilex Pharms's Drug Patents
Given below is the list of recent legal activities going on the following drug patents of Scilex Pharms.
| Activity | Date | Patent Number |
|---|---|---|
 | ||
| Surcharge for Late Payment, Large Entity | 26 Jun, 2024 | US10799517 |
| Payment of Maintenance Fee, 4th Year, Large Entity | 26 Jun, 2024 | US10799517 |
|
Maintenance Fee Reminder Mailed
Critical
| 03 Jun, 2024 | US10799517 |
|
Email Notification
Critical
| 01 Apr, 2024 | US10722456 |
|
Email Notification
Critical
| 01 Apr, 2024 | US10799517 |
|
Change in Power of Attorney (May Include Associate POA)
Critical
| 01 Apr, 2024 | US10722456 |
|
Change in Power of Attorney (May Include Associate POA)
Critical
| 01 Apr, 2024 | US10799517 |
|
Email Notification
Critical
| 29 Mar, 2024 | US10376527 |
|
Change in Power of Attorney (May Include Associate POA)
Critical
| 29 Mar, 2024 | US10376527 |
|
Email Notification
Critical
| 28 Mar, 2024 | US9795620 |
|
Change in Power of Attorney (May Include Associate POA)
Critical
| 28 Mar, 2024 | US9949990 |
|
Change in Power of Attorney (May Include Associate POA)
Critical
| 28 Mar, 2024 | US9572819 |
|
Email Notification
Critical
| 28 Mar, 2024 | US9572819 |
|
Change in Power of Attorney (May Include Associate POA)
Critical
| 28 Mar, 2024 | US9795620 |
|
Email Notification
Critical
| 28 Mar, 2024 | US9949990 |
Scilex Pharms's Family Patents
Scilex Pharms Drug List
Given below is the complete list of Scilex Pharms's drugs and the patents protecting them.
1. Elyxyb
Elyxyb is protected by 6 patents, out of which none have expired yet. Check out its patent list below.
| Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Status |
|---|---|---|---|
| US10376527 | Oral composition of celecoxib for treatment of pain |
27 May, 2036
(11 years from now)
| Active |
| US10722456 | Oral composition of celecoxib for treatment of pain |
27 May, 2036
(11 years from now)
| Active |
| US10799517 | Oral composition of celecoxib for treatment of pain |
27 May, 2036
(11 years from now)
| Active |
| US9572819 | Oral composition of celecoxib for treatment of pain |
27 May, 2036
(11 years from now)
| Active |
| US9795620 | Oral composition of celecoxib for treatment of pain |
27 May, 2036
(11 years from now)
| Active |
| US9949990 | Oral composition of celecoxib for treatment of pain |
27 May, 2036
(11 years from now)
| Active |
Discover which of these patents contain the active ingredient(API) of the drug, their family patents, along with litigation and legal activity details of these patents on Elyxyb's drug page
2. Gloperba
Gloperba is protected by 4 patents, out of which none have expired yet. Check out its patent list below.
| Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Status |
|---|---|---|---|
| US10226423 | Colchicine drug-to-drug interactions |
20 Dec, 2037
(13 years from now)
| Active |
| US10383820 | Colchicine drug-to-drug interactions |
22 Nov, 2036
(12 years from now)
| Active |
| US10383821 | Colchicine drug-to-drug interactions |
22 Nov, 2036
(12 years from now)
| Active |
| US9907751 | Composition and method of use of colchicine oral liquid |
22 Nov, 2036
(12 years from now)
| Active |
Discover which of these patents contain the active ingredient(API) of the drug, their family patents, along with litigation and legal activity details of these patents on Gloperba's drug page
3. Ztlido
Ztlido is protected by 8 patents, out of which none have expired yet. Check out its patent list below.
| Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Status |
|---|---|---|---|
| US10765640 | Non-aqueous patch |
10 May, 2031
(6 years from now)
| Active |
| US10765749 | Non-aqueous patch |
10 May, 2031
(6 years from now)
| Active |
| US11278623 | Non-aqueous patch |
10 May, 2031
(6 years from now)
| Active |
| US11786455 | Non-aqueous patch |
10 May, 2031
(6 years from now)
| Active |
| US11793766 | Non-aqueous patch for the relief of pain |
10 May, 2031
(6 years from now)
| Active |
| US9283174 | Non-aqueous patch |
10 May, 2031
(6 years from now)
| Active |
| US9925264 | Non-aqueous patch |
10 May, 2031
(6 years from now)
| Active |
| US9931403 | Non-aqueous patch |
10 May, 2031
(6 years from now)
| Active |
Discover which of these patents contain the active ingredient(API) of the drug, their family patents, along with litigation and legal activity details of these patents on Ztlido's drug page